Oklo's Groves Reactor Clears Final Safety Hurdle, Targets July Criticality
Event summary
- The DOE approved Oklo's Documented Safety Analysis for the Groves Isotope Test Reactor in Texas.
- This marks the final safety review step before startup approval and first criticality, targeted for July 2026.
- Groves is the first advanced reactor project on privately owned land with commercially sourced fuel and systems.
- The facility aims to establish a domestic supply chain for critical isotopes used in medicine, manufacturing, and national security.
The big picture
Oklo's Groves reactor represents a strategic shift in advanced nuclear deployment, demonstrating that private companies can navigate DOE regulatory processes on commercial timelines. The project underscores growing U.S. efforts to secure domestic supply chains for critical materials while advancing next-generation energy technologies. Success here could accelerate broader adoption of small modular reactors and other advanced fission systems.
What we're watching
- Regulatory Precedent
- Whether Groves' approval sets a new benchmark for private-sector advanced reactor deployments under DOE oversight.
- Commercial Timelines
- The pace at which Oklo can replicate this success with future commercial-scale facilities.
- Supply Chain Impact
- How Groves' domestic isotope production could disrupt existing global supply chains for critical medical and industrial isotopes.
Related topics